CAD 0.04
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 7.3 Million CAD | -6.48% |
2022 | 7.81 Million CAD | -7.39% |
2021 | 8.43 Million CAD | 39.26% |
2020 | 6.06 Million CAD | 220.25% |
2019 | 1.89 Million CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 7.64 Million CAD | 4.61% |
2024 Q3 | 6.44 Million CAD | 4.22% |
2024 Q2 | 6.38 Million CAD | -16.5% |
2023 Q2 | 7.18 Million CAD | 0.7% |
2023 Q1 | 7.12 Million CAD | -8.77% |
2023 FY | 7.3 Million CAD | -6.48% |
2023 Q4 | 7.3 Million CAD | 4.88% |
2023 Q3 | 6.96 Million CAD | -2.94% |
2022 Q4 | 7.81 Million CAD | -4.18% |
2022 Q1 | 8.29 Million CAD | -1.67% |
2022 Q3 | 8.15 Million CAD | 0.81% |
2022 FY | 7.81 Million CAD | -7.39% |
2022 Q2 | 8.09 Million CAD | -2.5% |
2021 Q3 | 6.89 Million CAD | 4.08% |
2021 Q2 | 6.62 Million CAD | 10.23% |
2021 Q1 | 6 Million CAD | -0.89% |
2021 Q4 | 8.43 Million CAD | 22.47% |
2021 FY | 8.43 Million CAD | 39.26% |
2020 Q1 | 6.34 Million CAD | 235.11% |
2020 FY | 6.06 Million CAD | 220.25% |
2020 Q4 | 6.06 Million CAD | -6.53% |
2020 Q3 | 6.48 Million CAD | 1.28% |
2020 Q2 | 6.4 Million CAD | 0.95% |
2019 Q1 | - CAD | 0.0% |
2019 Q3 | 881.5 Thousand CAD | 0.0% |
2019 Q4 | 1.89 Million CAD | 114.67% |
2019 FY | 1.89 Million CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 5.06 Million CAD | -44.345% |
Decibel Cannabis Company Inc. | 40.96 Million CAD | 82.157% |
Delivra Health Brands Inc. | 2.02 Million CAD | -260.597% |
Entourage Health Corp. | 161.58 Million CAD | 95.476% |
Lifeist Wellness Inc. | 1.26 Million CAD | -477.347% |
Cannara Biotech Inc. | 45.78 Million CAD | 84.035% |
Medicure Inc. | 544 Thousand CAD | -1243.622% |
PharmaCielo Ltd. | 18.3 Million CAD | 60.077% |
Rubicon Organics Inc. | 10.25 Million CAD | 28.756% |
BioSyent Inc. | 1.22 Million CAD | -498.611% |
Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -18173.26% |